Abstract
It has been suggested that glucagon-like immunoreactivity (GLI) of gastrointestinal tissues might, like pancreatic glucagon, have calcium-lowering activity. Studies were designed, therefore, to determine if calcium absorption was associated with GLI release from the gut. The intraduodenal administration of 4.5 mmoles of calcium chloride per kg of body weight to conscious dogs was associated with a prompt rise in plasma GLI from a base line of 2.2 ng/ml (SEM ±0.2) to a peak of 4.3 ng/ml (SEM ±0.3) at 45 and 60 min, in association with a rise of plasma calcium from 8.6 to 10.4 mg/100 ml. Neither pancreatic glucagon, insulin, nor glucose changed. Smaller calcium loads had progressively diminishing effects on GLI release. Calcium lactate also appeared to stimulate effectively GLI release. Both magnesium chloride and sodium chloride given intraduodenally were associated with a significant though modest increase in GLI.
To determine if stimulation of GLI release by substances other than calcium would lower serum calcium, glucose was administered intraduodenally. Despite a marked increase in GLI, plasma calcium fell only 9%, a decline which could be entirely accounted for by hemodilution.
Although the physiologic significance of this demonstration that the absorption of calcium salts is associated with GLI release is open to serious question, the findings are not incompatible with the concept that glucagon-like polypeptides are released from the gut during the absorption of certain salts, possibly to alert appropriate homeostatic regulators so as to avoid major changes in electrolyte concentration after the ingestion of large salt loads.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aguilar-Parada E., Eisentraut A. M., Unger R. H. Pancreatic glucagon secretion in normal and diabetic subjects. Am J Med Sci. 1969 Jun;257(6):415–419. doi: 10.1097/00000441-196906000-00008. [DOI] [PubMed] [Google Scholar]
- Birge S. J., Avioli L. V. Glucagon-induced hypocalcemia in man. J Clin Endocrinol Metab. 1969 Feb;29(2):213–218. doi: 10.1210/jcem-29-2-213. [DOI] [PubMed] [Google Scholar]
- Dupré J., Rojas L., White J. J., Unger R. H., Beck J. C. Effects of secretin on insulin and glucagon in portal and peripheral blood in man. Lancet. 1966 Jul 2;2(7453):26–27. doi: 10.1016/s0140-6736(66)91750-8. [DOI] [PubMed] [Google Scholar]
- Floyd J. C., Jr, Fajans S. S., Conn J. W., Knopf R. F., Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest. 1966 Sep;45(9):1487–1502. doi: 10.1172/JCI105456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Herbert V., Lau K. S., Gottlieb C. W., Bleicher S. J. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965 Oct;25(10):1375–1384. doi: 10.1210/jcem-25-10-1375. [DOI] [PubMed] [Google Scholar]
- Marco J., Faloona G. R., Unger R. H. Effect of endogenous intestinal glucagon-like immunoreactivity (GLI) on insulin secretion and glucose concentration in dogs. J Clin Endocrinol Metab. 1971 Aug;33(2):318–325. doi: 10.1210/jcem-33-2-318. [DOI] [PubMed] [Google Scholar]
- Moody A. J., Markussen J., Fries A. S., Steenstrup C., Sundby F. The insulin releasing activites of extracts of pork intestine. Diabetologia. 1970 Apr;6(2):135–140. doi: 10.1007/BF00421441. [DOI] [PubMed] [Google Scholar]
- Samols E., Tyler J., Megyesi C., Marks V. Immunochemical glucagon in human pancreas, gut, and plasma. Lancet. 1966 Oct 1;2(7466):727–729. doi: 10.1016/s0140-6736(66)92982-5. [DOI] [PubMed] [Google Scholar]
- Unger R. H., Ketterer H., Eisentraut A. M. Distribution of immunoassayable glucagon in gastrointestinal tissues. Metabolism. 1966 Oct;15(10):865–867. doi: 10.1016/0026-0495(66)90156-9. [DOI] [PubMed] [Google Scholar]
- Unger R. H., Ohneda A., Valverde I., Eisentraut A. M., Exton J. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose. J Clin Invest. 1968 Jan;47(1):48–65. doi: 10.1172/JCI105714. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Valverde I., Rigopoulou D., Marco J., Faloona G. R., Unger R. H. Characterization of glucagon-like immunoreactivity (GLI). Diabetes. 1970 Sep;19(9):614–623. doi: 10.2337/diab.19.9.614. [DOI] [PubMed] [Google Scholar]
- YALOW R. S., BERSON S. A. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960 Jul;39:1157–1175. doi: 10.1172/JCI104130. [DOI] [PMC free article] [PubMed] [Google Scholar]